Journal rankings · indicator year 2014
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2014
Cancer Research journal rankings 2014
23 ranked journals · Subfield in Biochemistry, Genetics and Molecular Biology
Cancer Research has 23 ranked journals in 2014. The median journal has an OJR of 0.88, below the world average of 1.00, down 0.04 on 2013; Q1 starts at OJR 1.24. The top three are Biomedicine, Mutation Research/Reviews in Mutation Research, and Journal of Molecular Diagnostics.
Ranks and citation indicators: 2014. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2011–2013, the window the 2014 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Biochemistry, Genetics and Molecular Biology (14)
23 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2013. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2011–2013, the window the 2014 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2011–2013 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2005 to 2014. | Compare |
|---|---|---|---|---|---|---|---|
1BiomedicineOAEDP Sciences · Netherlands | 3.32Q1 | 7.75 6.64 up from 2013 | 66 | 100% | — | ||
2Mutation Research/Reviews in Mutation ResearchElsevier BV · Netherlands | 2.57Q1 | 8.07 0.06 down from 2013 | 73 | 24% | $4,160 | ||
3Journal of Molecular DiagnosticsElsevier BV · United States | 2.06Q1 | 5.84 1.40 up from 2013 | 279 | 100% | $3,000 | ||
4Breast Cancer Research and TreatmentSpringer Science+Business Media · Netherlands | 1.41Q1 | 4.72 0.10 down from 2013 | 1,465 | 47% | $4,190 | ||
5Biomarker InsightsOASAGE Publishing · United Kingdom | 1.26Q1 | 3.19 0.23 up from 2013 | 46 | 100% | $2,650 | ||
6Critical Reviews in Eukaryotic Gene ExpressionBegell House · United States | 1.24Q1 | 2.47 0.72 down from 2013 | 84 | 14% | — | ||
7Mutation Research/Genetic Toxicology and Environmental MutagenesisElsevier BV · Netherlands | 1.23Q2 | 3.04 0.22 down from 2013 | 477 | 17% | $3,350 | ||
8Journal of Molecular SignalingOABioMed Central · United Kingdom | 1.13Q2 | 3.65 0.16 up from 2013 | 44 | 100% | — | ||
9Environmental and Molecular MutagenesisWiley · United States | 1.10Q2 | 3.17 0.36 up from 2013 | 231 | 32% | $3,750 | ||
10The BreastOAElsevier BV · United Kingdom | 0.93Q2 | 2.77 0.32 down from 2013 | 574 | 88% | $3,200 | ||
11Clinical Breast CancerElsevier BV · United States | 0.91Q2 | 2.44 0.83 down from 2013 | 250 | 21% | $3,470 | ||
12MutagenesisOxford University Press · United Kingdom | 0.88Q2 | 3.21 0.22 up from 2013 | 234 | 45% | $4,170 | ||
13British Journal of Biomedical ScienceOATaylor & Francis · United Kingdom | 0.82Q3 | 2.07 1.05 up from 2013 | 68 | 3% | $2,506 | ||
14Journal of Breast CancerOASouth Korea | 0.80Q3 | 2.26 0.14 up from 2013 | 203 | 100% | $500 | ||
15Pathology - Research and PracticeElsevier BV · Germany | 0.76Q3 | 1.73 0.17 down from 2013 | 433 | 7% | $2,780 | ||
16Breast Cancer Basic and Clinical ResearchOASAGE Publishing · United States | 0.75Q3 | 2.05 0.16 down from 2013 | 45 | 100% | $2,650 | ||
17The Breast JournalOAWiley · United Kingdom | 0.67Q3 | 1.68 0.08 down from 2013 | 367 | 58% | $2,350 | ||
18Breast CancerSpringer Science+Business Media · Japan | 0.62Q3 | 1.90 0.08 up from 2013 | 254 | 15% | $3,890 | ||
19Journal of Biomaterials and Tissue EngineeringAmerican Scientific Publishers · United States | 0.57Q4 | 1.28 0.40 up from 2013 | 139 | 5% | — | ||
20Breast DiseaseIOS Press · Netherlands | 0.55Q4 | 1.26 0.08 up from 2013 | 48 | 4% | — | ||
21Breast Diseases A Year Book QuarterlyElsevier BV · Netherlands | 0.31Q4 | 1.00no change | 610 | 1% | — | ||
22International Journal of Human GeneticsOAKamla Raj Enterprises · India | 0.11Q4 | 0.32 0.09 up from 2013 | 177 | 2% | — | ||
23Genes and EnvironmentOABioMed Central · Japan | 0.10Q4 | 0.34 0.10 down from 2013 | 73 | 100% | $2,590 |
Subfields of Biochemistry, Genetics and Molecular Biology, with Cancer Research highlighted.
- Molecular Biology1,034
- Genetics108
- Cell Biology25
- Cancer Research23
- Molecular Medicine10
- Biophysics7
- Clinical Biochemistry3
- Biochemistry2
- Structural Biology2
- Aging1
- Developmental Biology1
- Physiology1
- Biotechnology0
- Endocrinology0
Journals
Citations made in 2014. Corpus-wide, 77.7% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
22 additional Cancer Research journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2011–2013, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2014. Publication window: 2011–2013. How these summaries are calculated
- Ranked journals
- 23
- Window papers (baseline)
- 44,722 +24.4% from indicator year 2011
- Median OJR
- 0.88 +9.8% from indicator year 2011
- Rising journals (2025)
- 2
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2011–2013 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 12 | 14 | 15 | 16 | 16 | 19 | 20 | 21 | 21 | 22 | 21 | 20 | 21 | 24 | 23 | 25 | 26 | 27 | 28 | 27 | 29 | 27 | 27 | 26 | 27 | 29 | |
| Window papers (baseline) | 14,247 | 15,312 | 16,615 | 17,745 | 18,774 | 20,529 | 22,718 | 25,259 | 27,535 | 30,135 | 32,914 | 35,940 | 38,839 | 41,424 | 44,722 | 47,640 | 50,019 | 51,182 | 52,328 | 54,530 | 57,576 | 61,698 | 64,508 | 64,646 | 60,806 | 56,699 | |
| Median OJR | 0.49 | 0.50 | 0.46 | 0.60 | 0.71 | 0.58 | 0.67 | 0.680 | 0.768 | 0.8139 | 0.72 | 0.798 | 0.93 | 0.92 | 0.88 | 0.84 | 0.7969 | 0.8143 | 0.804 | 0.82 | 0.76 | 0.679 | 0.70 | 0.79 | 0.770 | 0.7966 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.